Common genetic risk factors for venous thrombosis in the chinese population

American Journal of Human Genetics

Volumn 92, Issue 2, 2013, Pages 177-187

  Tang, Liang ^a   Wang, Hua Fang ^a   Lu, Xuan ^a   Jian, Xiao Rong ^a   Jin, Bi ^a   Zheng, Hong ^a   Li, Yi Qing ^a   Wang, Qing Yun ^a   Wu, Tang Chun ^b   Guo, Huan ^b   Liu, Hui ^a   Guo, Tao ^a   Yu, Jian Ming ^a   Yang, Rui ^a   Yang, Yan ^a   Hu, Yu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THROMBOMODULIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ETHNICITY; FEMALE; FIRST DEGREE RELATIVE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEMOSTASIS; HETEROZYGOTE; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DISEASE-FREE SURVIVAL; FAMILY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RISK FACTORS; SOLUBILITY; THROMBOMODULIN; VENOUS THROMBOSIS;

EID: 84873718689     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.12.013     Document Type: Article

References (60)

1. L.E. Flinterman, A. van Hylckama Vlieg, S.C. Cannegieter, and F.R. Rosendaal Long-term survival in a large cohort of patients with venous thrombosis: Incidence and predictors PLoS Med. 9 2012 e1001155
2. R.H. White The epidemiology of venous thromboembolism Circulation 107 23, Suppl 1 2003 I4 I8
3. P.D. Stein, F. Kayali, R.E. Olson, and C.E. Milford Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: Analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census Am. J. Med. 116 2004 435 442
4. R.H. White, H. Zhou, S. Murin, and D. Harvey Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996 Thromb. Haemost. 93 2005 298 305
5. L.N. Roberts, R.K. Patel, and R. Arya Venous thromboembolism and ethnicity Br. J. Haematol. 146 2009 369 383
6. N.A. Zakai, and L.A. McClure Racial differences in venous thromboembolism J. Thromb. Haemost. 9 2011 1877 1882
7. P.E. Morange, I. Bezemer, N. Saut, L. Bare, G. Burgos, J. Brocheton, H. Durand, C. Biron-Andreani, J.F. Schved, and G. Pernod A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1 Am. J. Hum. Genet. 86 2010 592 595
8. M.E. Meltzer, T. Lisman, C.J. Doggen, P.G. de Groot, and F.R. Rosendaal Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis PLoS Med. 5 2008 e97
9. F.R. Rosendaal Venous thrombosis: A multicausal disease Lancet 353 1999 1167 1173
10. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722
11. I.D. Bezemer, L.A. Bare, C.J. Doggen, A.R. Arellano, C. Tong, C.M. Rowland, J. Catanese, B.A. Young, P.H. Reitsma, J.J. Devlin, and F.R. Rosendaal Gene variants associated with deep vein thrombosis JAMA 299 2008 1306 1314
12. S.C. Christiansen, I.A. Naess, S.C. Cannegieter, J. Hammerstrøm, F.R. Rosendaal, and P.H. Reitsma Inflammatory cytokines as risk factors for a first venous thrombosis: A prospective population-based study PLoS Med. 3 2006 e334
13. F.A. Anderson Jr., and F.A. Spencer Risk factors for venous thromboembolism Circulation 107 23, Suppl 1 2003 I9 I16
14. J.C. Souto, L. Almasy, M. Borrell, F. Blanco-Vaca, J. Mateo, J.M. Soria, I. Coll, R. Felices, W. Stone, J. Fontcuberta, and J. Blangero Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Genetic Analysis of Idiopathic Thrombophilia Am. J. Hum. Genet. 67 2000 1452 1459
15. U. Seligsohn, and A. Lubetsky Genetic susceptibility to venous thrombosis N. Engl. J. Med. 344 2001 1222 1231
16. B. Dahlbäck, M. Carlsson, and P.J. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C Proc. Natl. Acad. Sci. USA 90 1993 1004 1008
17. T. Koster, F.R. Rosendaal, H. de Ronde, E. Briët, J.P. Vandenbroucke, and R.M. Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506
18. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. de Ronde, P.A. van der Velden, and P.H. Reitsma Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
19. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
20. J. Corral, D. Hernandez-Espinosa, J.M. Soria, R. Gonzalez-Conejero, A. Ordonez, J.R. Gonzalez-Porras, E. Perez-Ceballos, R. Lecumberri, I. Sanchez, and V. Roldan Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis Blood 109 2007 4258 4263
21. L. Tang, T. Guo, R. Yang, H. Mei, H. Wang, X. Lu, J. Yu, Q. Wang, and Y. Hu Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population PLoS ONE 7 2012 e35773
22. L. Tang, X. Lu, J.M. Yu, Q.Y. Wang, R. Yang, T. Guo, H. Mei, and Y. Hu PROC c.574-576del polymorphism: A common genetic risk factor for venous thrombosis in the Chinese population J. Thromb. Haemost. 10 2012 2019 2026
23. N. Hamasaki Unmasking Asian thrombophilia: Is APC dysfunction the real culprit? J. Thromb. Haemost. 10 2012 2016 2018
24. B. Dahlbäck Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood 112 2008 19 27
25. J. Corral, J. Aznar, R. Gonzalez-Conejero, P. Villa, A. Miñano, A. Vayá, R.W. Carrell, J.A. Huntington, and V. Vicente Homozygous deficiency of heparin cofactor II: Relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis Circulation 110 2004 1303 1307
26. M.E. Meltzer, T. Lisman, P.G. de Groot, J.C. Meijers, S. le Cessie, C.J. Doggen, and F.R. Rosendaal Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 Blood 116 2010 113 121
27. J.A. Heit, J.M. Cunningham, T.M. Petterson, S.M. Armasu, D.N. Rider, and M. DE Andrade Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism J. Thromb. Haemost. 9 2011 1133 1142
28. B. Saposnik, J.L. Reny, P. Gaussem, J. Emmerich, M. Aiach, and S. Gandrille A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis Blood 103 2004 1311 1318
29. C.T. Esmon, and W.G. Owen Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C Proc. Natl. Acad. Sci. USA 78 1981 2249 2252
30. B. Dahlbäck, and B.O. Villoutreix Regulation of blood coagulation by the protein C anticoagulant pathway: Novel insights into structure-function relationships and molecular recognition Arterioscler. Thromb. Vasc. Biol. 25 2005 1311 1320
31. H. Weiler, and B.H. Isermann Thrombomodulin J. Thromb. Haemost. 1 2003 1515 1524
32. B. Isermann, R. Sood, R. Pawlinski, M. Zogg, S. Kalloway, J.L. Degen, N. Mackman, and H. Weiler The thrombomodulin-protein C system is essential for the maintenance of pregnancy Nat. Med. 9 2003 331 337
33. M. Delvaeye, M. Noris, A. De Vriese, C.T. Esmon, N.L. Esmon, G. Ferrell, J. Del-Favero, S. Plaisance, B. Claes, and D. Lambrechts Thrombomodulin mutations in atypical hemolytic-uremic syndrome N. Engl. J. Med. 361 2009 345 357
34. N.A. Horowitz, E.A. Blevins, W.M. Miller, A.R. Perry, K.E. Talmage, E.S. Mullins, M.J. Flick, K.C. Queiroz, K. Shi, and C.A. Spek Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain Blood 118 2011 2889 2895
35. K.K. Wu TM hidden treasure: Lectin-like domain Blood 119 2012 1103 1104
36. H. Bounameaux, and F.R. Rosendaal Venous thromboembolism: Why does ethnicity matter? Circulation 123 2011 2189 2191
37. X. Wang, and I.M. El Naqa Prediction of both conserved and nonconserved microRNA targets in animals Bioinformatics 24 2008 325 332
38. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, and S.R. Sunyaev A method and server for predicting damaging missense mutations Nat. Methods 7 2010 248 249
39. R.W. Jackman, D.L. Beeler, L. Fritze, G. Soff, and R.D. Rosenberg Human thrombomodulin gene is intron depleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control Proc. Natl. Acad. Sci. USA 84 1987 6425 6429
40. L. Le Flem, V. Picard, J. Emmerich, S. Gandrille, J.N. Fiessinger, M. Aiach, and M. Alhenc-Gelas Mutations in promoter region of thrombomodulin and venous thromboembolic disease Arterioscler. Thromb. Vasc. Biol. 19 1999 1098 1104
41. G. Kunz, H.A. Ireland, P.J. Stubbs, M. Kahan, G.C. Coulton, and D.A. Lane Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction Blood 95 2000 569 576
42. G. Kunz, A.K. Ohlin, A. Adami, B. Zöller, P. Svensson, and D.A. Lane Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function Blood 99 2002 3646 3653
43. N. Aleksic, A.R. Folsom, M. Cushman, S.R. Heckbert, M.Y. Tsai, and K.K. Wu Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: The LITE Study J. Thromb. Haemost. 1 2003 88 94
44. S. Sugiyama, H. Hirota, R. Kimura, Y. Kokubo, T. Kawasaki, E. Suehisa, A. Okayama, H. Tomoike, T. Hayashi, and K. Nishigami Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population Thromb. Res. 119 2007 35 43
45. J.A. Heit, T.M. Petterson, W.G. Owen, J.P. Burke, M. DE Andrade, and L.J. Melton 3rd Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: A population-based case-control study J. Thromb. Haemost. 3 2005 710 717
46. P. Kubisz, J. Stasko, P. Hollý, J. Ivanková, and R. Pullmann More on: Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: A population-based case-control study J. Thromb. Haemost. 3 2005 2825 2827
47. L. Le Flem, L. Mennen, M.L. Aubry, M. Aiach, P.Y. Scarabin, J. Emmerich, and M. Alhenc-Gelas Thrombomodulin promoter mutations, venous thrombosis, and varicose veins Arterioscler. Thromb. Vasc. Biol. 21 2001 445 451
48. J.L. Reny, V. Remones, P. Fontana, I. Bieche, F. Desvard, M.L. Aubry, P. Gaussen, and M. Aiach The thrombomodulin-1208/-1209delTT gene promoter polymorphism does not affect basal or LPS-dependent monocyte TM mRNA transcription in healthy volunteers Thromb. Haemost. 94 2005 686 687
49. V. Salomaa, C. Matei, N. Aleksic, L. Sansores-Garcia, A.R. Folsom, H. Juneja, L.E. Chambless, and K.K. Wu Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study Lancet 353 1999 1729 1734
50. A. Leizorovicz, A.G. Turpie, A.T. Cohen, L. Wong, M.C. Yoo, A. Dans SMART Study Group Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study J. Thromb. Haemost. 3 2005 28 34
51. M. Sakuma, M. Nakamura, N. Yamada, S. Ota, K. Shirato, T. Nakano, M. Ito, and T. Kobayashi Venous thromboembolism: Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone Circ. J. 73 2009 305 309
52. S. Ikeda, and Y. Miyahara Ethnicity of patients with venous thromboembolism. -The incidence of venous thromboembolism in an Asian population- Circ. J. 75 2011 1831 1832
53. Y. Yang, L. Liang, Z. Zhai, H. He, W. Xie, X. Peng, C. Wang Investigators for National Cooperative Project for Prevention and Treatment of PTE-DVT Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: A multicenter registration study PLoS ONE 6 2011 e26861
54. P.E. Morange, and D.A. Tregouet Lessons from genome-wide association studies in venous thrombosis J. Thromb. Haemost. 9 Suppl 1 2011 258 264
55. J.M. Wason, and F. Dudbridge A general framework for two-stage analysis of genome-wide association studies and its application to case-control studies Am. J. Hum. Genet. 90 2012 760 773
56. T.A. Manolio Genomewide association studies and assessment of the risk of disease N. Engl. J. Med. 363 2010 166 176
57. P. Prandoni, F. Bilora, A. Marchiori, E. Bernardi, F. Petrobelli, A.W. Lensing, M.H. Prins, and A. Girolami An association between atherosclerosis and venous thrombosis N. Engl. J. Med. 348 2003 1435 1441
58. C.J. Doggen, V.M. Cats, R.M. Bertina, and F.R. Rosendaal Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A Circulation 97 1998 1037 1041
59. H. Ireland, G. Kunz, K. Kyriakoulis, P.J. Stubbs, and D.A. Lane Thrombomodulin gene mutations associated with myocardial infarction Circulation 96 1997 15 18
60. K.K. Wu, N. Aleksic, C. Ahn, E. Boerwinkle, A.R. Folsom, H. Juneja Atherosclerosis Risk in Communities Study (ARIC) Investigators Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease Circulation 103 2001 1386 1389